Residual brain viability, evaluated by 99mTc-ECD SPECT, in patients with suspected brain death and with confounding clinical factors
- 1 October 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Nuclear Medicine Communications
- Vol. 30 (10), 815-821
- https://doi.org/10.1097/mnm.0b013e32832ff5f8
Abstract
In 1968, the Harvard criteria for brain death diagnosis were introduced in clinical practice. These include no movements or breathing, no reflexes, and flat electroencephalogram in the absence of confounding factors, including hypothermia, drugs, electrolyte, and endocrine disturbances. When confounding factors occur, confirmatory tests documenting the absence of cerebral blood flow, such as cerebral angiogram, transcranial Doppler sonography, computed tomography angiography, and nuclear techniques, are required. The aim of this study was to evaluate the clinical value of single-photon emission computed tomography (SPECT) with technetium-99m (99mTc)-ECD in the diagnosis of brain death in a cohort of patients with confounding factors. Fifty-two patients were studied between 1 January 2000 and 23 September 2008. The criteria for the request for 99mTc-ECD SPECT were sodic thiopental withdrawal after less than 24 h, unreceptivity and unresponsivity of brainstem reflexes, anesthesia in the last 24 h, hypothermia, anamnesis for barbiturate use, electroencephalogram artefacts, toxic state, and pediatric criteria. All patients underwent 99mTc-ECD SPECT using a dual-headed camera fitted with a high-resolution low-energy collimator. Images were reconstructed and processed according to standard procedures and interpreted qualitatively by two experienced observers. The presence of spots of residual brain viability was observed in 13 patients: 25% of our patient cohort. The patients with residual viability were younger (aged 30.92±17.28 years) in comparison with those with no viability (41.91±18.77 years, PConclusion In patients with confounding factors in whom brain death diagnosis is equivocal, 99mTc-ECD SPECT is a helpful and safe diagnostic approach, allowing a three-dimensional evaluation of cortical and brainstem viability. It guarantees an unequivocal diagnosis of brain death for patients who are potential candidates for organ donation. The persistence of viable spots of brain tissue was found in 25% of our patients and was more frequent in young patients. This affects the opposition to donation.Keywords
This publication has 12 references indexed in Scilit:
- Radionuclide Studies in the Determination of Brain Death: Criteria, Concepts, and ControversiesSeminars in Nuclear Medicine, 2008
- Limitations of brain death in the interpretation of computed tomographic angiographyIntensive Care Medicine, 2007
- Limitations of computed tomographic angiography in the diagnosis of brain deathIntensive Care Medicine, 2007
- Tc‐99m‐HMPAO SPECT in the diagnosis of brain death in childrenPediatrics International, 2004
- Irreversible apnoeic coma 35 years laterIntensive Care Medicine, 2004
- Radiologic Diagnosis of Brain DeathJAMA, 2002
- Brain death worldwideNeurology, 2002
- Brain death revisited: utility confirmed for nuclear medicine.European Journal of Nuclear Medicine and Molecular Imaging, 1999
- Dissociation of cerebral blood flow, glucose metabolism, and electrical activity in pediatric brain deathJournal of Neurosurgery, 1993
- A Definition of Irreversible ComaJAMA, 1968